Which manufcaturer is launching authorized generic for incruse ellipta?

Who is launching the authorized generic for Incruse Ellipta?

Authorized generic versions of Incruse Ellipta (umeclidinium) are being launched by Teva Pharmaceuticals USA, Inc. as the authorized-generic manufacturer.

How does DrugPatentWatch describe the authorized-generic launch?

DrugPatentWatch lists Teva as the authorized-generic entrant for Incruse Ellipta and provides related patent/exclusivity context. [1]

Sources:
[1] https://www.drugpatentwatch.com/